New Sleep Medicine Dosing Guidelines from the FDA

There have been many questions asked about a new study that recommends that women use 5 mg of Zolpidem, or Ambien. The U.S. Food and Drug Administration (FDA) is requiring lower current recommended doses of Ambien, Ambien CR, Edluar and Zolpimist, widely used sleep drugs that contain the active ingredient Zolpidem.

New data show that Zolpidem (Ambien) blood levels in some patients may be high enough the morning after use to impair activities that require alertness, including driving. Using lower doses of Zolpidem (Ambien) means that less of the drug will remain in the blood in the morning hours.

Since women eliminate Zolpidem (Ambien) from their bodies more slowly than men, the FDA states that the recommended dose should be lowered for women.

The recommended highest dose of Zolpidem (Ambien) will be 5 mg for women and 10 mg for men. In the long-acting Zolpidem (Ambien CR) recommended doses are 6.25 mg for women and 12.5 mg for men.

Please speak to your health care provider for advice about your dosage.

Patients who must drive in the morning or perform some other activity requiring full alertness should talk to their health care professional abut whether their sleep medicine is appropriate.